Literature DB >> 14569272

Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia.

R Hashimoto1, R E Straub, C S Weickert, T M Hyde, J E Kleinman, D R Weinberger.   

Abstract

Genetic linkage and association have implicated neuregulin-1 (NRG-1) as a schizophrenia susceptibility gene. We measured mRNA expression levels of the three major isoforms of NRG-1 (ie type I, type II, and type III) in the postmortem dorsolateral prefrontal cortex (DLPFC) from matched patients and controls using real-time quantitative RT-PCR. Expression levels of three internal controls-GAPDH, cyclophilin, and beta-actin-were unchanged in schizophrenia, and there were no changes in the absolute levels of the NRG-1 isoforms. However, type I expression normalized by GAPDH levels was significantly increased in schizophrenia DLPFC (by 23%) and positively correlated with antipsychotic medication dosage. Type II/type I and type II/type III ratios were significantly decreased (18 and 23% respectively). There was no effect on the NRG-1 mRNA levels of genotype at two SNPs previously associated with schizophrenia, suggesting that these alleles are not functionally responsible for abnormal NRG-1 expression patterns in patients. Subtle abnormalities in the expression patterns of NRG-1 mRNA isoforms in DLPFC may be associated with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14569272     DOI: 10.1038/sj.mp.4001434

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  96 in total

Review 1.  Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.

Authors:  Kristen J Brennand; Fred H Gage
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

2.  Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli.

Authors:  S B Taylor; A R Taylor; J A Markham; A M Geurts; B Z Kanaskie; J I Koenig
Journal:  Physiol Behav       Date:  2010-11-16

Review 3.  Gene expression in the etiology of schizophrenia.

Authors:  Nicholas J Bray
Journal:  Schizophr Bull       Date:  2008-03-11       Impact factor: 9.306

Review 4.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

Review 5.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

6.  Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Authors:  J D Buxbaum; L Georgieva; J J Young; C Plescia; Y Kajiwara; Y Jiang; V Moskvina; N Norton; T Peirce; H Williams; N J Craddock; L Carroll; G Corfas; K L Davis; M J Owen; S Harroch; T Sakurai; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2007-04-17       Impact factor: 15.992

7.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

8.  ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms.

Authors:  Daria Krivosheya; Lucia Tapia; Joshua N Levinson; Kun Huang; Yunhee Kang; Rochelle Hines; Annie K Ting; Ann Marie Craig; Lin Mei; Shernaz X Bamji; Alaa El-Husseini
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

9.  Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls.

Authors:  Fei Wang; Tianzi Jiang; Zhiguo Sun; Siew-Leng Teng; Xingguang Luo; Zhongjun Zhu; Yufeng Zang; Handi Zhang; Weihua Yue; Mei Qu; Tianlan Lu; Nan Hong; Haiyan Huang; Hilary P Blumberg; Dai Zhang
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 10.  Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Authors:  Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.